LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High-Tech Microscope Constructed for Low Cost

By LabMedica International staff writers
Posted on 08 Dec 2014
Image: The low cost microscope system constructed to perform multiple simultaneous time-lapse studies on various cell types (Photo courtesy of Adam Lynch).
Image: The low cost microscope system constructed to perform multiple simultaneous time-lapse studies on various cell types (Photo courtesy of Adam Lynch).
The direct visualization of cells for the purpose of studying their motility has typically required expensive microscopy equipment; however, recent advances in digital sensors mean that it is now possible to image cells for a fraction of the price of a standard microscope.

The development and performance of an expandable cell motility system has been described that employs inexpensive, commercially available digital Universal Serial Bus (USB) microscopes to image various cell types using time-lapse and perform tracking assays.

Scientists at Brunel University (Uxbridge, UK) constructed the apparatus from cheaply bought materials. Various lighting sources were tested, and ultimately a light-emitting diode (LED) strip desk lamp was selected. An incubation chamber was developed to fit over the top of the stage and the chamber was made from transparent acrylic to allow visualization inside.

The three microscopes used were identical models (VMS-004D, Veho; Southampton, UK) in order to prevent any discrepancies. These microscopes use a complementary metal–oxide–semiconductor (CMOS) image sensor with 1.3 mega-pixel resolution. Magnification has two set levels, from approximately ×20 minimum to around ×400 maximum, achieved using a focusing wheel. To enhance stability, magnification and to allow for observation of live samples in liquid (cells) the microscopes were inverted.

The imaging capability of the system was compared to a conventional inverted microscope fitted with a 1.3 megapixel camera. The highest magnification on the conventional microscope was greater than the constructed system, but the maximum pixel resolution of images was the same. Spatial resolution on the conventional microscope was higher and intra-cellular detail could be seen at the highest magnification that could not be distinguished in the innovative system when images were enlarged to match the size.

The authors concluded that the novel cell tracking system had the ability to perform multiple simultaneous time-lapse studies on various cell types. Due to its low-cost, portability and commercially available components they believe that this system has the potential to enable time-lapse studies by non-specialist departments, and may be a practical solution for scientists with limited financial resources. The study was published on August 14, 2014, in the journal Public Library of Science ONE.

Related Links:

Brunel University 
Veho 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Clinical Chemistry Analyzer
Envoy 500+
Gold Member
Neonatal Heel Incision Device
Tenderfoot

Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more